Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6411635rdf:typepubmed:Citationlld:pubmed
pubmed-article:6411635lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C0007097lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:6411635lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:6411635pubmed:issue3lld:pubmed
pubmed-article:6411635pubmed:dateCreated1983-10-21lld:pubmed
pubmed-article:6411635pubmed:abstractTextDuring the years from 1974 to 1977, 30 patients were treated for carcinoma of the oro-facial region with a combination of 5-fluoro-uracil and telecobalt under the care of the Institute of Radiotherapy, Knappschafts-Krankenhaus, Recklinghausen. 13 of these patients were inoperable and had primary irradiation therapy, and the remaining 17 patients were irradiated postoperatively. The main effect that treatment showed was a rapid response in the inoperable tumors, while the 4- to 5-year survival rates of 1:13 of the inoperable cases and 6:17 of the operated patients are in accordance with generally accepted results. The possible radio-biologic relation to this is discussed.lld:pubmed
pubmed-article:6411635pubmed:languageenglld:pubmed
pubmed-article:6411635pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411635pubmed:citationSubsetDlld:pubmed
pubmed-article:6411635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411635pubmed:statusMEDLINElld:pubmed
pubmed-article:6411635pubmed:monthJunlld:pubmed
pubmed-article:6411635pubmed:issn0300-9785lld:pubmed
pubmed-article:6411635pubmed:authorpubmed-author:WillC HCHlld:pubmed
pubmed-article:6411635pubmed:authorpubmed-author:DieckmannJJlld:pubmed
pubmed-article:6411635pubmed:authorpubmed-author:HeringK GKGlld:pubmed
pubmed-article:6411635pubmed:issnTypePrintlld:pubmed
pubmed-article:6411635pubmed:volume12lld:pubmed
pubmed-article:6411635pubmed:ownerNLMlld:pubmed
pubmed-article:6411635pubmed:authorsCompleteYlld:pubmed
pubmed-article:6411635pubmed:pagination141-6lld:pubmed
pubmed-article:6411635pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:meshHeadingpubmed-meshheading:6411635-...lld:pubmed
pubmed-article:6411635pubmed:year1983lld:pubmed
pubmed-article:6411635pubmed:articleTitleCombination of 5-fluoro-uracil and Co60 irradiation in the treatment of carcinoma of the oro-facial region. A follow-up investigation of 30 patients.lld:pubmed
pubmed-article:6411635pubmed:publicationTypeJournal Articlelld:pubmed